A Study to Assess the Use of Methylone in the Treatment of PTSD
Clinical trial NCT05741710 · COMPLETED
Trial details
- NCT number
- NCT05741710
- Sponsor
- Transcend Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-02-19
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.